1. End-of-life care in cystic fibrosis
- Author
-
Robinson, Walter M., Ravilly, Sophie, Berde, Charles, and Wohl, Mary Ellen
- Subjects
Cystic fibrosis -- Care and treatment ,Critically ill children -- Care and treatment ,Terminal care -- Analysis - Abstract
Care given to young dying patients with cystic fibrosis (CF) appears to differ from the care given to dying children with cancer. Analyses done on end-of-life medical records of 44 young patients with CF revealed that most patients continued receiving pain and antibiotic medications until the last hours of life. Most patients received varying amounts of opiate medications for varying lengths of time to reduce pain and labored breathing. Nearly all patients died while hospitalized under orders not to resuscitate., Objective. End-of-life clinical care in cystic fibrosis (CF) differs substantially from terminal care in childhood cancer. To examine this difference, we reviewed the medical care of a cohort of CF patients treated at Children's Hospital, Boston, to document the use of preventive, therapeutic, and palliative care in the month preceding death. Patients. We reviewed the medical records of 44 patients older than 5 years who died of CF-related respiratory failure for the years 1984 to 1993. Results. Thirty-eight patients (86%) received opiates for the treatment of severe dyspnea and pain; the duration of opiate use varied from less than 1 hour to greater than 1 month. The dose of opiates varied from less than 5 mg per hour to greater than 30 mg per hour. Thirty-three patients (75%) continued to receive intravenous antibiotics in the last 12 hours of life; 32 (72%) continued to receive preventive or therapeutic oral medications in the last 12 hours of life. All patients were designated as do not resuscitate at the time of death; 43 of the patients died in the hospital with 1 patient dying at home under hospice care. Conclusions. The model of comfort care developed in childhood cancer does not adequately describe the combination of preventive, therapeutic, and palliative care given at the end of life for CF at our institution. The majority of CF patients continued to receive intravenous antibiotics and/or oral vitamin preparations while being treated with opiates for terminal pain and dyspnea. Small doses of opiates seem to be effective in the treatment of the pain and dyspnea at the end of life in CF. Pediatrics 1997;100:205-209; cystic fibrosis palliative care, terminal care., ABBREVIATIONS. CF, cystic fibrosis; FEV[1], mean forced expiratory volume at one second; DNR, do not resuscitate; BiPAP, biphasic positive airway pressure. Cystic fibrosis (CF) is the most common lethal childhood [...]
- Published
- 1997